United Kingdom

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

17 Jul 2019
Change (% chg)

$-1.80 (-1.10%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Hugin, Robert 

Mr. Robert J. Hugin is Director of the company. As Chairman and Chief Executive Officer of Celgene Corporation, Mr. Hugin was instrumental in the strategic growth of the company, overseeing the expansion of Celgene from a U.S.-based biopharmaceutical company to a global company with operations in more than 50 countries. Mr. Hugin is a member of the Board of Trustees ofPrinceton University, the Board of Trustees at the Darden School of Business at theUniversity of Virginiaand is past Chairman of the Board of The Pharmaceutical Research and Manufacturers of America. Mr. Hugin formerly served on the boards of Danaher Corporation, The Medicines Company, Coley Pharmaceutical Group and Atlantic Health System.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --